Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) — Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage…
Month: August 2022
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering Methods of Treating Sepsis with Allocetra™
Nes-Ziona, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Bavarian Nordic Enters Additional Contract with APAC Country for Supply of Smallpox/Monkeypox Vaccine in 2023
Larger order for 2023 follows initial order for supply in 2022 COPENHAGEN, Denmark, August 3,…
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference
BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Capricor Therapeutics to Present Second Quarter 2022 Financial Results and Recent Corporate Update on August 10
Company to Host Conference Call, August 10, 2022, at 4:30 p.m. ET SAN DIEGO, Aug….
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Catalyst Stockholders Vote “FOR” All of the Company’s Nominees on the WHITE Proxy Card
ISS and Glass Lewis Highlight That Stockholders Are Best Served by Allowing the Incumbent Board…
CytomX Therapeutics to Present at Upcoming Virtual August Investor Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
Mersana Therapeutics to Host Second Quarter 2022 Conference Call on August 8, 2022 and Present at Upcoming Conferences
CAMBRIDGE, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…
Black Diamond Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
CAMBRIDGE, Mass. and NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Journey Medical Corporation to Announce Second Quarter 2022 Financial Results on August 9, 2022
Company to host conference call to discuss financial results and provide a corporate update on…
Neoleukin Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference
SEATTLE, Aug. 03, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Enzo Biochem Appoints Matthew Kupferberg as General Counsel
NEW YORK, NY, Aug. 03, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo”…
BioAtla to Participate in the 2022 BTIG Biotechnology Conference
SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
Cornerstone Pharmaceuticals Announces Successful Completion of Phase 1b Clinical Trial for CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer
CRANBURY, N.J., Aug. 03, 2022 (GLOBE NEWSWIRE) — Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”),…
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2022
Continued enrollment of EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis Announced…
Landos Biopharma Reports Positive Top-Line Results From NX-13 Phase 1b Trial
NX-13 Demonstrated Favorable Safety and Tolerability Profile Across Range of Once-Daily Doses Results Indicate Promising…
Ocuphire Extends U.S. Patent Protection for Late-Stage Drug Candidate Nyxol® for Reversal of Mydriasis by Five More Years into 2039 with New Patent Issuance
Issuance Extends Nyxol’s U.S. Patent Protection from 2034 into 2039 for RM Indication Growing Patent…
Vericel Reports Second Quarter 2022 Financial Results
Second Quarter Total Net Revenue of $37.0 Million MACI Net Revenue of $28.6 Million Conference…
Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics
§ Lesion swab (standard of care) and saliva-based sample collection planned § Peer-reviewed publication demonstrating saliva testing…
Acerus to Report Q2-2022 Financial Results and Host Investor Call
TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its…